High-throughput miRNA sequencing of the human placenta: expression throughout gestation

Epigenomics. 2021 Jul;13(13):995-1012. doi: 10.2217/epi-2021-0055. Epub 2021 May 25.

Abstract

Aim: To understand miRNA changes across gestation in healthy human placentae. This is essential before miRNAs can be used as biomarkers or prognostic indicators during pregnancy. Materials & methods: Using next-generation sequencing, we characterize the normative human placenta miRNome in first (n = 113) and third trimester (n = 47). Results & conclusion: There are 801 miRNAs expressed in both first and third trimester, including 182 with similar expression across gestation (p ≥ 0.05, fold change ≤2) and 180 significantly different (false discovery rate <0.05, fold change >2). Of placenta-specific miRNA clusters, chromosome 14 miRNA cluster decreases across gestation and chromosome 19 miRNA cluster is overall highly expressed. Chromosome 13 clusters are upregulated in first trimester. This work provides a rich atlas of healthy pregnancies to direct functional studies investigating the epigenetic differences in first and third trimester placentae.

Keywords: chorionic villi; gestational differences; human transcriptome; miRNA; miRNA atlas; miRNome; placenta; pregnancy; stable miRNAs; uncomplicated pregnancies.

Plain language summary

Lay abstract The human body produces miRNAs which affect the expression of genes and proteins. This study uses next-generation sequencing to identify the miRNA profile of first and third trimester human placentae using a large cohort (n = 113 first trimester; n = 47 third trimester). All pregnancies resulted in healthy babies. We identify miRNAs with significantly different expression between first and third trimester, as well as stably expressed miRNAs. This work provides a baseline for future studies which may use miRNAs to monitor maternal–fetal health throughout pregnancy.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Biomarkers
  • Computational Biology / methods
  • Female
  • Gene Expression Profiling*
  • Gene Expression Regulation*
  • Gestational Age
  • High-Throughput Nucleotide Sequencing*
  • Humans
  • Male
  • MicroRNAs / genetics*
  • Placenta / metabolism*
  • Pregnancy
  • Pregnancy Outcome
  • Transcriptome

Substances

  • Biomarkers
  • MicroRNAs